Keyphrases
Peru
100%
Systemic Lupus Erythematosus
82%
Lupus
67%
Peruvian
65%
COVID-19
56%
Latin American
56%
Rheumatology
54%
Spain
49%
Multi-ethnic
47%
Systemic Lupus Erythematosus Patient
46%
Lima
46%
Latin America (LATAM)
43%
Confidence Interval
38%
Tuberculosis
34%
Madrid
31%
Remission
30%
Rheumatic Diseases
28%
Damage Accrual
25%
SLE Disease Activity Index (SLEDAI)
24%
Low Disease Activity
21%
Disease Activity
21%
Dolostone
20%
AIDS/HIV
18%
Odds Ratio
18%
National Hospital
17%
Antiretroviral Therapy
17%
Pulmonary Tuberculosis
16%
COVID-19 Pandemic
16%
Multivariable
16%
Latino
16%
Multidrug-resistant Tuberculosis (MDR-TB)
16%
Rheumatoid Arthritis
16%
Age at Diagnosis
15%
Rheumatologists
15%
Systematic Literature Review
15%
Patient Data
15%
Risk Factors
15%
American College of Rheumatology
15%
Tuberculosis Transmission
14%
Building Stone
14%
Drug Susceptibility Testing
14%
Parkinson's Disease
14%
Liver Transplantation
14%
Health-related Quality of Life
14%
COVID-19 Outcomes
13%
Emergency Department
13%
Systemic Lupus International Collaborating Clinics
13%
HIV Patients
13%
Quarry
12%
Salt Crystallization
12%
Clinical Features
12%
Latent Tuberculosis Infection
12%
Prednisone
12%
Damage Index
12%
Predictors of Remission
12%
Low Disease Activity State
12%
Lumen
12%
Huntington's Disease
12%
Building Materials
11%
Archaeological Sites
11%
Clinical Characteristics
11%
Humidity
11%
Mestizo
11%
Comorbidity
10%
Built Heritage
10%
Mortar
10%
American College of Rheumatology Criteria
10%
Microscopic Observation Drug Susceptibility
10%
Conservation Treatment
10%
Patina
9%
Meta-analysis
9%
Faade
9%
Ultrasound Velocity
9%
Immunosuppressive Drugs
9%
Mycobacterium Tuberculosis (M. tb)
9%
Lupus Nephritis
9%
Hospitalization
9%
Archaeological Ceramics
9%
ANCA-associated Vasculitis
9%
Suicidal Ideation
9%
Calcium Hydroxide Nanoparticles
9%
Emerita
9%
Clinical Practice Guidelines
9%
Brick
9%
Cough Frequency
9%
Stone Substrate
9%
Hospitalized Patients
9%
Hazard Ratio
8%
Epidemiology
8%
Parkinson Patients
8%
Clinical Manifestations
8%
Firing Temperature
8%
Granitic Rocks
8%
Cough
8%
Tuberculosis Diagnosis
8%
SLICC
8%
Granulomatosis with Polyangiitis
8%
United States
8%
Infectiousness
8%
Pan American
8%
Medicine and Dentistry
Systemic Lupus Erythematosus
84%
Rheumatology
61%
Lupus Erythematosus
51%
Disease
49%
COVID-19
47%
Disease Activity
44%
Human Immunodeficiency Virus
35%
Rheumatic Disease
34%
Tuberculosis
17%
Rheumatoid Arthritis
17%
Inflammatory Arthritis
17%
SLEDAI
17%
Drug Sensitivity
16%
Infection
14%
Systematic Review
14%
Multidrug Resistant Tuberculosis
13%
ANCA Associated Vasculitis
12%
Prevalence
12%
Coughing
12%
Odds Ratio
12%
Antiretroviral Therapy
12%
Quality of Life
11%
Liver Transplantation
11%
Antimalarial Agent
11%
Health Care Cost
10%
Prednisone
10%
Emergency Department
10%
Drug Resistance
10%
Latent Tuberculosis
9%
Diagnosis
9%
Lung Tuberculosis
9%
Public Health
9%
Health Care
9%
Patient-Data
9%
Infection Control
9%
Observational Study
8%
Clinical Feature
8%
Immunosuppressive Drug
8%
Granulomatosis with Polyangiitis
8%
Huntington's Disease
7%
Lupus Nephritis
7%
Liver Graft
7%
Mycobacterium Tuberculosis
7%
Calcium Oxide
7%
Transplantation
7%
Drug Therapy
7%
Cross Sectional Study
7%
Cohort Effect
7%
Glucocorticoid
7%
Pediatrics
6%
Hazard Ratio
6%
Influenza Virus
6%
Hepatocellular Carcinoma
6%
Disease Modifying Antirheumatic Drug
6%
Diffuse Large B-Cell Lymphoma
6%
COVID-19 Vaccination
6%
Clinical Predictor
6%
Pre-Eclampsia
6%
6 Diazo 5 Oxonorleucine
6%
Influenza Vaccine
6%
Homocysteine
6%
Logistic Regression Analysis
6%
Mixed Infection
5%
Pyrazinamide
5%
Tuberculosis Treatment
5%
Sputum
5%
Microscopic Polyangiitis
5%
Human Immunodeficiency Virus Infection
5%
Linear Regression Analysis
5%
Comorbidity
5%
Diarrhea
5%
Severe Acute Respiratory Syndrome
5%